Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2008 | First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; CHIH-HSIN YANG ; SHANG-GIN WU ; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG ; Hsu Y.-C.; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 69 | 62 | |
2017 | First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study | Soria J.-C.; Tan D.S.W.; Chiari R.; Wu Y.-L.; Paz-Ares L.; Wolf J.; Geater S.L.; Orlov S.; Cortinovis D.; CHONG-JEN YU ; Hochmair M.; Cortot A.B.; Tsai C.-M.; Moro-Sibilot D.; Campelo R.G.; McCulloch T.; Sen P.; Dugan M.; Pantano S.; Branle F.; Massacesi C.; de Castro G.; Jr | The Lancet | 949 | 771 | |
2016 | First-line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in Asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer the ASPIRATION study | Park K.; CHONG-JEN YU ; Kim S.-W.; Lin M.-C.; Sriuranpong V.; Tsai C.-M.; Lee J.-S.; Kang J.-H.; Chan K.C.A.; Perez-Moreno P.; Button P.; Ahn M.-J.; Mok T. | JAMA Oncology | 200 | 164 | |
2023 | First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial | Kim, Hye Ryun; Sugawara, Shunichi; Lee, Jong-Seok; Kang, Jin-Hyoung; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; CHONG-JEN YU ; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko | Cancer medicine | 1 | 0 | |
2007 | Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: Associated genetic mutations and relationship to antimicrobial exposure | JANN-YUAN WANG ; LI-NA LEE ; HSIN-CHIH LAI ; Wang S.-K.; I-SHIOW JAN ; CHONG-JEN YU ; PO-REN HSUEH ; PAN-CHYR YANG | Journal of Antimicrobial Chemotherapy | 120 | 111 | |
2013 | Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | SHANG-GIN WU ; Hu F.-C.; YIH-LEONG CHANG ; Lee Y.-C.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Wu J.-Y.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 35 | 36 | |
2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
2020 | Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma | Lu, Hsuan-Hsuan; SHU-YUNG LIN ; Weng, Rueyhung Roc; Juan, Yi-Hsiu; Chen, Yen-Wei; HSIN-HAN HOU ; Hung, Zheng-Ci; Oswita, Giovanni Audrey; Huang, Yi-Jhen; Guu, Shih-Yun; Khoo, Kay-Hooi; JIN-YUAN SHIH ; CHONG-JEN YU ; HSING-CHEN TSAI | EBioMedicine | 21 | 15 | |
2013 | Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer | Chen C.-Y.; Jan Y.-H.; Juan Y.-H.; Yang C.-J.; Huang M.-S.; CHONG-JEN YU ; PAN-CHYR YANG ; Hsiao M.; Hsu T.-L.; Wong C.-H. | Proceedings of the National Academy of Sciences of the United States of America | 215 | 189 | |
2020 | Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients | CHUN-TA HUANG ; CHUN-MING HONG ; Tsai Y.-J.; WANG-HUEI SHENG ; CHONG-JEN YU | BMC Gastroenterology | 3 | 2 | |
2017 | Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan | LIH-YU CHANG ; Lee C.-H.; JEN-CHANG KO ; Chang L.-Y.; Lee M.-C.; JANN-YUAN WANG ; CHONG-JEN YU | Cancer Medicine | 8 | 7 | |
2011 | Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations | Wu J.-Y.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 32 | 27 | |
2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIUN HSU ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 12 | 10 | |
2013 | Gefitinib-related interstitial lung disease in Taiwanese patients with non-small-cell lung cancer | Chang S.-C.; Chang C.-Y.; Chang S.-J.; Yuan M.-K.; Lai Y.-C.; Liu Y.-C.; Chen C.-Y.; Kuo L.-C.; CHONG-JEN YU | Clinical Lung Cancer | 17 | 13 | |
2008 | Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial | CHIUN HSU ; SUNG-HSIN KUO ; Hu F.-C.; ANN-LII CHENG ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIA-CHI LIN ; Huang T.-C.; PAN-CHYR YANG ; CHIH-HSIN YANG | Lung Cancer | 14 | 11 | |
2015 | Gender-based impact of epidermal growth factor receptor mutation in patients with nonsmall cell lung cancer and previous tuberculosis | Chang C.-H.; Lee C.-H.; CHAO-CHI HO ; JANN-YUAN WANG ; CHONG-JEN YU | Medicine (United States) | 17 | 14 | |
2015 | Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment | JANN-YUAN WANG ; Tsai, Ching Hui; YUNG-LING LEE; LI-NA LEE ; CHIA-LIN HSU ; Chang, Hsiu Ching; JONG-MIN CHEN ; Hsu, Cheng An; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 22 | 15 | |
2004 | Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD | Cheng S.-L.; CHONG-JEN YU ; Chen C.-J.; PAN-CHYR YANG | European Respiratory Journal | 122 | 115 | |
2012 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum | WEI-YU LIAO ; JIN-YUAN SHIH ; Chang G.-C.; Cheng Y.-K.; CHIH-HSIN YANG ; Chen Y.-M.; CHONG-JEN YU | Journal of Thoracic Oncology | 50 | 50 | |
2009 | Genetic Polymorphisms of Cytochrome P450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease | Cheng S.-L.; CHONG-JEN YU ; PAN-CHYR YANG | Biochemical Genetics | 26 | 24 | |